Company Filing History:
4 out of 525 
3 out of 444 
1 out of 15,462 
Years Active: 2012-2018
Title: Frank Furnari: Innovator in Cancer Research
Introduction
Frank Furnari is a notable inventor based in La Jolla, California. He has made significant contributions to the field of cancer research, particularly in the development of innovative methods targeting mutant genes. With a total of four patents to his name, Furnari's work has the potential to impact cancer treatment significantly.
Latest Patents
Furnari's latest patents include compositions and methods for inhibiting the expression of the mutant EGFR gene. This invention relates to a double-stranded ribonucleic acid (dsRNA) that targets a mutant Epidermal Growth Factor Receptor (EGFR). The methods developed by Furnari aim to inhibit the expression of this mutant EGFR, which is crucial in various cancer types.
Career Highlights
Throughout his career, Frank Furnari has worked with prestigious organizations such as the Ludwig Institute for Cancer Research Limited and Alnylam Pharmaceuticals, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Furnari has collaborated with notable colleagues, including Webster K. Cavenee and Dinah Sah. These partnerships have further enhanced his research and innovation in cancer therapies.
Conclusion
Frank Furnari's contributions to cancer research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in cancer treatment and gene therapy.